Icecure Medical Ltd (NASDAQ:ICCM) currently has a daily average trading volume of 773.64K but it saw 1375194 shares traded in last market. With a market cap of 29.21M USD, the company’s current market price of $0.59 came rising about 7.27 while comparing to the previous closing price of $0.55. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.57 and as low as $0.48. In the recent trading on the day, stock has struck highest price mark of $0.56 while lowest mark touched by it was $0.6399.
Taking a look at 20-day trading activity of Icecure Medical Ltd (ICCM) gives us an average price of $0.6753, while its current price level is -62.42% below from 52-week high level whereas it is 22.92% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6345 while that of 200 days or SMA-200 reads an average of $0.9148. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.54% during that period while stretching the period over a month that decreases to 12.41%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.84 which implies that the stock is in neutral territory.
Over the week, ICCM’s stock price is moving -20.26% down while it is 9.18% when we observe its performance for the past one month. Year-to-date it is -44.86% down and over the past year, the stock is showing a downside performance of -20.27%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -0.09 beat the consensus estimate of -0.09 for the same. The company is expected to be releasing its next quarterly report in December, for which analysts forecasted an EPS of -0.08 while estimate for next year EPS is -0.28. In next quarter, company is expected to be making quarterly sales of $1.29M as analysts are expecting the sales for current fiscal year at $4M and seeing the company making $7.97M in sales next year. Moreover, analysts are in estimates of $708.5k for current-quarter revenue.
Currently, Icecure Medical Ltd’s total number of outstanding shares is 45.73M. Company’s return on investment (ROI) stands at -125.79% and return on equity (ROE) at -94.22%. Stock has a price to book (P/B) ratio of 2.75 while price to sale or P/S ratio amounts to 8.75. Its return on asset (ROA) is -71.93% on average.
